Alcohol Withdrawal Medication Selection

Treat alcohol-withdrawal seizures, delirium, marked autonomic instability, or inability to safely receive and report symptom-triggered therapy as complicated withdrawal requiring monitored acute-care management. Withdrawal manifestations may begin within 8 hours of the last alcohol intake, peak at 24 to 72 hours, and occur alongside cardiopulmonary, infectious, arrhythmic, bleeding, and other medical complications that can change both drug selection and disposition. PubMedPubMedPatient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review - PMC

Use CIWA-Ar only when the patient can reliably answer subjective questions and nursing reassessment can drive dosing. Dementia, language barriers, delirium, intubation, or other communication limitations make CIWA-Ar unreliable; in these settings, use a protocol based on objective bedside assessment, including a sedation/agitation scale when available, and select therapy that can be safely monitored in the care setting. ScienceDirect+1ScienceDirectBarbiturates for the treatment of alcohol withdrawal syndrome: A systematic review of clinical trials - ScienceDirectPubMedPatient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review - PMC

For patients whose clinical state may represent another process, do not attribute persistent delirium, hypoxemia, fever, focal neurologic findings, or hemodynamic instability to withdrawal alone. Evaluate and treat competing acute illness while treating withdrawal, because alcohol withdrawal commonly coexists with infection, cardiopulmonary insufficiency, arrhythmia, and bleeding disorders. PubMedPubMedPatient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review - PMC

Use a benzodiazepine as first-line medication for clinically significant alcohol withdrawal. Benzodiazepines are recommended to relieve withdrawal discomfort and to prevent seizures and delirium; evidence reviews also found benzodiazepines more effective than placebo for reducing alcohol-withdrawal seizures. nice org uk+2nice org uk[PDF] Alcohol-use disorders: physical complications Evidence Update ...nice org uk[PDF] CG100: Alcohol-use disorders - NICEWHOMental Health, Brain Health and Substance Use

Choose a long-acting agent when hepatic metabolism is preserved because long-acting benzodiazepines are generally preferred for alcohol withdrawal. When hepatic metabolism is impaired, including liver failure, or in older adults, choose a shorter-acting benzodiazepine rather than applying the long-acting preference without adjustment. WHOWHOMental Health, Brain Health and Substance Use

Use symptom-triggered treatment when serial assessment is dependable. One cited inpatient regimen used lorazepam 2 mg orally every 2 to 8 hours, while fixed tapering lorazepam began at 2 to 8 mg three times daily according to severity; these dosing examples should be embedded in a local protocol with reassessment for oversedation, respiratory compromise, and persistent withdrawal. Wolters KluwerWolters KluwerIn hospitalized patients undergoing alcohol withdrawal, does ... - Ovid

For severe withdrawal, use front-loaded dosing with a longer-acting benzodiazepine when monitoring is available. Do not prolong treatment merely because insomnia, anxiety, or tremor persists after the acute withdrawal window; treatment duration should be individualized but generally limited to 3 to 7 days after cessation. Wolters Kluwer+1Wolters KluwerManaging the Complex Intersection Between... : JACCP: Journal of the American College of Clinical PharmacyWHOMental Health, Brain Health and Substance Use

Consider phenobarbital as an alternative to benzodiazepines or as an adjunct when severe withdrawal persists despite benzodiazepine treatment, when benzodiazepines cause problematic adverse effects, or when a structured critical-care or emergency-department protocol is available. Phenobarbital has been used both alone and with benzodiazepines, and systematic reviews describe similar or potentially improved outcomes versus alternative therapy, although severe withdrawal definitions and prospective randomized data remain limited. ScienceDirect+2ScienceDirectA prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal - ScienceDirectPubMedPatient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review - PMCnice org uk[PDF] Appendix A: Summary of evidence from surveillance | NICE

For an emergency-department patient managed with a symptom-triggered lorazepam protocol, one randomized trial evaluated a single intravenous phenobarbital load of 10 mg/kg. Compared with lorazepam protocol alone, the phenobarbital-loaded group had fewer ICU admissions without an increased adverse-event rate; a subsequent retrospective replication did not find a statistically significant between-group difference. This supports phenobarbital loading as a protocol option, not as a universal replacement for benzodiazepines. PubMedPubMedManagement of Alcohol Withdrawal in the Emergency Department: Current Perspectives - PMC

In mild-to-moderate withdrawal, phenobarbital did not outperform IV lorazepam plus oral chlordiazepoxide in a 44-patient randomized emergency-department study for effectiveness, emergency-department length of stay, admission, or symptoms 48 hours after discharge. Select phenobarbital for a clear clinical or operational advantage rather than routine use in every lower-acuity presentation. PubMedPubMedManagement of Alcohol Withdrawal in the Emergency Department: Current Perspectives - PMC

The principal tradeoff is additive central nervous system and respiratory depression when phenobarbital is layered onto benzodiazepines. Use a defined loading and reassessment protocol, document all sedative exposure, and ensure the monitoring environment can detect oversedation and respiratory deterioration. Evidence syntheses characterize phenobarbital as generally well tolerated, but the evidence base includes small trials and observational studies. PubMed+2PubMedPatient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review - PMCnice org uk[PDF] Appendix A: Summary of evidence from surveillance | NICEPubMedManagement of Alcohol Withdrawal in the Emergency Department: Current Perspectives - PMC

Do not use antipsychotic medication as monotherapy for alcohol withdrawal. If hallucinations or severe agitation remain clinically dangerous after withdrawal-directed medication has been initiated, an antipsychotic may serve only as an adjunct; it does not provide the seizure- and delirium-preventive role of benzodiazepines. WHOWHOMental Health, Brain Health and Substance Use

Do not use anticonvulsants in place of benzodiazepines after an alcohol-withdrawal seizure. A review of 56 anticonvulsant studies involving 4,076 patients found no significant advantage over placebo for alcohol-withdrawal seizures, adverse events, or treatment discontinuation, even though carbamazepine reduced end-of-treatment CIWA-Ar scores more than benzodiazepines in some comparisons. nice org uk+2nice org uk[PDF] Alcohol-use disorders: physical complications Evidence Update ...nice org uk[PDF] CG100: Alcohol-use disorders - NICEWHOMental Health, Brain Health and Substance Use

Carbamazepine and gabapentin may be considered as monotherapy for mild-to-moderate alcohol withdrawal in selected patients, but this limited role should not be extended to seizure-associated or delirious withdrawal. Carbamazepine has evidence for symptom-score reduction, whereas broader anticonvulsant evidence does not establish prevention of severe withdrawal outcomes. Wolters Kluwer+3Wolters KluwerTrends in the Management of Inpatients With Alcohol... : Addictive Disorders & Their TreatmentWolters KluwerManaging the Complex Intersection Between... : JACCP: Journal of the American College of Clinical Pharmacynice org uk[PDF] Alcohol-use disorders: physical complications Evidence Update ...WHOMental Health, Brain Health and Substance Use

Alpha-adrenergic agonists, beta-blockers, dexmedetomidine, and similar agents may be encountered as adjuncts for selected autonomic or agitation targets, but they are not substitutes for GABAergic withdrawal treatment. When using any adjunct, continue a benzodiazepine- or phenobarbital-based strategy that addresses seizure and delirium risk. PubMed+1PubMedPatient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review - PMCWHOMental Health, Brain Health and Substance Use

At each reassessment, distinguish persistent withdrawal from medication toxicity and from an alternative cause of delirium. Worsening agitation despite treatment may indicate inadequate withdrawal control, but declining arousal or respiratory compromise after benzodiazepine or phenobarbital exposure should prompt immediate reassessment of additional sedative dosing and level of care. Phenobarbital and benzodiazepines are both used in ICU-level severe withdrawal pathways because close monitoring is central to safe escalation. ScienceDirect+2ScienceDirectBarbiturates for the treatment of alcohol withdrawal syndrome: A systematic review of clinical trials - ScienceDirectPubMedPatient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review - PMCPubMedManagement of Alcohol Withdrawal in the Emergency Department: Current Perspectives - PMC

Escalate to higher-acuity monitoring for recurrent seizures, withdrawal delirium, uncontrolled agitation despite protocolized therapy, or clinically important respiratory/sedation risk after cumulative sedative treatment. Severe alcohol withdrawal has been associated with mechanical ventilation and longer ICU stays; studies of phenobarbital-containing regimens suggest potential reductions in these outcomes, but the populations and definitions vary. PubMed+1PubMedPatient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review - PMCnice org uk[PDF] Appendix A: Summary of evidence from surveillance | NICE

Do not confuse completion of detoxification with treatment of alcohol use disorder. Supported withdrawal should be followed by treatment for alcohol dependence, and acute psychoactive medication should be dispensed in small quantities or under supervision when outpatient administration is used to reduce misuse risk. WHOWHOMental Health, Brain Health and Substance Use